Table 3 Comparison of S.aureus antibiotic susceptibility between AKUHN and GCH isolates
Antibiotic | AKUHN (N = 529) | GCH (N = 202) | P-value |
|---|---|---|---|
n (%) | n (%) | ||
Penicillin | 46 (8.7%) | 11 (5.4%) | 0.166 |
Oxacillin | 504 (95.3%) | 200 (99.0%) | 0.015 |
Erythromycin | 459 (86.8%) | 186 (92.1%) | 0.054 |
Clindamycina | 473 (89.4%) | 185 (91.6%) | 0.412 |
Gentamicin | 510 (96.4%) | 200 (99.0%) | 0.080 |
Tobramycin | 506 (95.7%) | 202 (100.0%) | 0.001 |
Levofloxacin | 487 (92.1%) | 200 (99.0%) | 0.000 |
Moxifloxacin | 522 (98.7%) | 202 (100.0%) | 0.199 |
Linezolid | 529 (100.0%) | 202 (100.0%) | 1.000 |
Mupirocin | 529 (100.0%) | 202 (100.0%) | 1.000 |
Rifampicin | 524 (99.1%) | 201 (99.5%) | 1.000 |
TMP/SMXb | 317 (59.9%) | 106 (52.5%) | 0.079 |
Tetracycline | 446 (84.3%) | 172 (85.1) | 0.820 |
Tigecycline | 529 (100.0%) | 202 (100.0%) | 1.000 |
Teicoplanin | 529 (100.0%) | 202 (100.0%) | 1.000 |
Vancomycin | 529 (100.0%) | 202 (100.0%) | 1.000 |